Zambon Group

Zambon S.p.a.

Franco Pozzi

Angelo Carenzi

Pia Furlani

Graziano Castaldi

Dario Tentorio

Claudio Giordano

Antonio Longo

Claudia Tortora

Claudio Girodano

A programmed release pharmaceutical dosage form comprising a core, containing the active ingredient, coated by a hydrophobic layer is described. Such dosage forms release the active ingredient after a pre-established no-release interval which does not depend on physiological factors.

Programmed release oral solid pharmaceutical dosage form

A process is described for the preparation of mono (2-ammonium-2-hydroxymethyl-1,3-propanediol) (2R,cis)-1,2-epoxypropyl-phosphonate with improved characteristics of stability, of processing for the preparation of pharmaceutical forms and of stability of the pharmaceutical forms that contain it.

Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)

Mono

The cap reservoir and dropper assembly for bottles includes a reservoir (1) fitted with a collar 913) adapted for resting on the mouth of a bottle (4), a delivery piston (2) the lower part of which is shaped like a flute mouthpiece (24) and the upper part of which is shaped like a collar (22). The assembly further includes a cap (3) the lower part of which is in the form of a removable strip (33). The delivery piston is equipped in its upper part with a dropper (23). The cap may be equipped with a feature which cooperates with the delivery piston collar to push the delivery piston downwards.

Cap, reservoir and dropper assembly for bottles

Pharmaceutical preparations for veterinary use, in the form of concentrate solutions, containing Thiamphenicol as active ingredient are described. Such pharmaceutical preparations with antibiotic activity have the following compositions:

Pharmaceutical preparation containing thiamphenicol for veterinary use

Pharamaceutical composition containing ubidecarenone

Growing community of inventors

Como, Italy

Franco Pozzi